184 related articles for article (PubMed ID: 29114247)
1. Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System.
Pupuleku A; Costa-García M; Farré D; Hengel H; Angulo A; Muntasell A; López-Botet M
Front Immunol; 2017; 8():1317. PubMed ID: 29114247
[TBL] [Abstract][Full Text] [Related]
2. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
3. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A
J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219
[TBL] [Abstract][Full Text] [Related]
4. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
5. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
[TBL] [Abstract][Full Text] [Related]
6. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
7. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
8. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
López-Botet M; Muntasell A; Vilches C
Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761
[TBL] [Abstract][Full Text] [Related]
9. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
10. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
11. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
12. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
Saether PC; Hoelsbrekken SE; Fossum S; Dissen E
J Immunol; 2011 Dec; 187(12):6365-73. PubMed ID: 22084441
[TBL] [Abstract][Full Text] [Related]
13. Adaptive NK cell response to human cytomegalovirus: Facts and open issues.
López-Botet M; De Maria A; Muntasell A; Della Chiesa M; Vilches C
Semin Immunol; 2023 Jan; 65():101706. PubMed ID: 36542944
[TBL] [Abstract][Full Text] [Related]
14. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
Noyola DE; Fortuny C; Muntasell A; Noguera-Julian A; Muñoz-Almagro C; Alarcón A; Juncosa T; Moraru M; Vilches C; López-Botet M
Eur J Immunol; 2012 Dec; 42(12):3256-66. PubMed ID: 22965785
[TBL] [Abstract][Full Text] [Related]
15. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
[TBL] [Abstract][Full Text] [Related]
16. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
17. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
18. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.
Hagberg N; Theorell J; Hjorton K; Spee P; Eloranta ML; Bryceson YT; Rönnblom L
Arthritis Rheumatol; 2015 Apr; 67(4):1000-11. PubMed ID: 25510434
[TBL] [Abstract][Full Text] [Related]
19. Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE
Front Immunol; 2019; 10():2403. PubMed ID: 31681293
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
